Virtual Kol Event: RZ402 - An Oral Plasma Kallikrein Inhibitor for DME - Wednesday, March 22, 2023 at 4:30 PM Edt

Learn More »

Rezolute profiled in Nature’s BioPharma Dealmakers, Nature Biotechnology, and Nature Reviews Drug Discovery, November 2019 editions

Back to Careers